American Society of Clinical Oncology
Tracked across 34 events · 491 articles · First seen May 06, 2025 · Last active Aug 24, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: The American Society of Clinical Oncology (ASCO) is the host of the annual meeting where new cancer research and clinical development advances are presented, making it a central entity for this event.
May 25, 2026 · 33 articles
Tech
Impact: The American Society of Clinical Oncology>>> Annual Meeting served as the platform for presenting the significant research findings on GLP-1 receptor agonist and breast cancer prevention.
Jun 02, 2026 · 45 articles
Tech
Impact: The American Society of Clinical Oncology is hosting its annual meeting where the groundbreaking results of the OPTIMA trial are being presented, disseminating the findings to a global audience of cancer specialists.
May 29, 2026 · 21 articles
Tech
Impact: ASCO highlighted the study in its press center and Science in Seconds, lending credibility to the technology.
Jul 06, 2026 · 6 articles
Tech
Impact: The American Society of Clinical Oncology hosted the annual meeting where the study results for SKB500 were presented, serving as a key platform for disseminating medical advancements.
Jun 03, 2026 · 6 articles
Domestic
Impact: ASCO co-organized the conference and partners with AORTIC for workforce development.
Jul 11, 2026 · 9 articles
Tech
In the weeks around the 2026 annual meeting of the American Society of Clinical Oncology, a wave of studies and media coverage suggested that GLP-1 drugs such as Ozempic might lower cancer risk. Observational studies…
Impact: The annual meeting served as a platform for presenting new research on GLP-1 drugs and cancer, contributing to the scientific discourse and media attention.
Jul 13, 2026 · 6 articles
Tech
Impact: The American Society of Clinical Oncology (ASCO) hosted the annual meeting where Dassault Systèmes — Medidata Solutions unveiled its new solution, serving as a platform for the announcement and contributing to the dissemination of the technology.
May 28, 2026 · 6 articles
Tech
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting served as the platform for Moleculin Biotech to present its positive cardiac safety data for Annamycin.
May 21, 2026 · 7 articles
Tech
Impact: The American Society of Clinical Oncology (ASCO) is hosting its Annual Meeting where Molecular Partners will present trial-in-progress poster presentations on MP0712.
May 30, 2026 · 8 articles
Tech
Impact: The American Society of Clinical Oncology Annual Meeting served as the platform for Orion to present its initial clinical data for ODM-212.
May 21, 2026 · 6 articles
Tech
Impact: The American Society of Clinical Oncology>>> is hosting the presentation of the trial results, solidifying its role as a central platform for disseminating significant cancer research. This event enhances its prestige and influence within the oncology community.
Jun 01, 2026 · 6 articles
Tech
Impact: The results of the amivantamab trial are being presented at the annual meeting of the American Society of Clinical Oncology, providing a platform for wider recognition of the breakthrough.
May 30, 2026 · 20 articles
Tech
Impact: The American Society of Clinical Oncology is hosting the annual meeting where Fulgent Genetics presented its FID-007 data, providing a platform for the dissemination of important clinical research.
May 21, 2026 · 8 articles
Tech
Impact: The meeting of the American Society of Clinical Oncology>>> highlighted significant studies and trial results for new life-extending cancer drugs.
Jun 03, 2026 · 6 articles
Tech
Impact: The organization hosted the annual meeting where the Phase III clinical study results were presented as an oral presentation, providing a platform for dissemination of the findings.
May 30, 2026 · 14 articles
Regulatory
Impact: ASCO is the venue where the clinical data supporting the BTD was presented. Its annual meeting serves as a platform for disseminating key efficacy and safety results, contributing to the credibility of the therapy.
Aug 03, 2026 · 6 articles
Tech
Impact: The American Society of Clinical Oncology meeting in Chicago was the venue where the significant findings of the daraxonrasib study were presented to the medical community.
May 29, 2026 · 74 articles
Tech
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting is the platform where the updated clinical data for IBI363 was presented, providing a significant forum for disseminating these important findings to the medical and scientific community.
May 21, 2026 · 9 articles
Tech
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting served as the platform for Dizal Pharmaceutical to present its clinical trial results, providing a credible forum for dissemination.
May 31, 2026 · 6 articles
Tech
Impact: The American Society of Clinical Oncology>>> meeting served as the platform for presenting the groundbreaking trial data for Apalutamide>>>.
May 31, 2026 · 6 articles
Tech
The American Society for Radiation Oncology (ASTRO) published an updated clinical practice guideline for radiation therapy in pancreatic cancer, revising its 2019 recommendations. The guideline, authored by Chuong et al. and published in Practical Radiation…
Impact: ASCO collaborated on the guideline, reinforcing its role in multidisciplinary cancer care and potentially influencing its members' practices.
Aug 13, 2026 · 6 articles
Tech
Moderna and Merck announced on August 19, 2026, that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy drug Pembrolizumab, met its primary and key secondary endpoints in a Phase 3 trial for…
Impact: ASCO's chief medical officer called the results a 'monumental leap forward,' and the organization hosted the Phase 2 data presentation.
Aug 19, 2026 · 108 articles
Regulatory
Impact: The RINGSIDE trial results were presented at the 2026 ASCO Annual Meeting, providing a platform for data dissemination.
Jul 08, 2026 · 6 articles
Business
Impact: ASCO hosted presentation of WU-KONG28 trial results as a Late-Breaking Abstract.
Jul 14, 2026 · 8 articles
Business
Impact: ASCO meetings provided the platform where positive data for the programs were presented, validating their potential.
Jul 21, 2026 · 7 articles
Business
Impact: ASCO is mentioned as the venue where results from the VIKTORIA-1 trial were presented. The event does not involve new ASCO actions, but the presentation is part of the company's clinical development history.
Aug 06, 2026 · 6 articles
+ 4 more events
View on Dashboard
ERGEN INTELLIGENCE
Track American Society of Clinical Oncology live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard